Literature DB >> 19628767

IGF-1R contributes to stress-induced hepatocellular damage in experimental cholestasis.

Axelle Cadoret1, Colette Rey, Dominique Wendum, Khaldoun Elriz, François Tronche, Martin Holzenberger, Chantal Housset.   

Abstract

The insulin-like growth factor type 1 receptor (IGF-1R) controls aging and cellular stress, both of which play major roles in liver disease. Stimulation of insulin-like growth factor signaling can generate cell death in vitro. Here, we tested whether IGF-1R contributes to stress insult in the liver. Cholestatic liver injury was induced by bile duct ligation in control and liver-specific IGF-1R knockout (LIGFREKO) mice. LIGFREKO mice displayed less bile duct ligation-induced hepatocyte damage than controls, while no differences in bile acid serum levels or better adaptation to cholestasis by efflux transporters were found. We therefore tested whether stress pathways contributed to this phenomenon; oxidative stress, ascertained by both malondialdehyde content and heme oxygenase-1 expression, was similar in knockout and control animals. However, together with a lower level of eukaryotic initiation factor-2 alpha phosphorylation, the endoplasmic reticulum stress protein CHOP and its downstream pro-apoptotic target Bax were induced to lesser extents in LIGFREKO mice than in controls. Expression levels of cytokeratin 19, transforming growth factor-beta1, alpha-smooth muscle actin, and collagen alpha1(I) in LIGFREKO mice were all lower than in controls, indicating reduced ductular and fibrogenic responses and increased cholestasis tolerance in these mutants. This stress resistance phenotype was also evidenced by longer post-bile duct ligation survival in mutants than controls. These results indicate that IGF-1R contributes to cholestatic liver injury, and suggests the involvement of both CHOP and Bax in this process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628767      PMCID: PMC2716962          DOI: 10.2353/ajpath.2009.081081

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

1.  Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis.

Authors:  Andrew D Clouston; Elizabeth E Powell; Meagan J Walsh; Michelle M Richardson; A Jake Demetris; Julie R Jonsson
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

2.  Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.

Authors:  Eduardo Schiffer; Chantal Housset; Wulfran Cacheux; Dominique Wendum; Christèle Desbois-Mouthon; Colette Rey; François Clergue; Raoul Poupon; Véronique Barbu; Olivier Rosmorduc
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

3.  Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells.

Authors:  Y Liu; S Lehar; C Corvi; G Payne; R O'Connor
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

4.  Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis.

Authors:  I Castilla-Cortazar; M Garcia; B Muguerza; J Quiroga; R Perez; S Santidrian; J Prieto
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

5.  c-myc-induced hepatocarcinogenesis in the absence of IGF-I receptor.

Authors:  Axelle Cadoret; Christèle Desbois-Mouthon; Dominique Wendum; Patricia Leneuve; Christine Perret; François Tronche; Chantal Housset; Martin Holzenberger
Journal:  Int J Cancer       Date:  2005-04-20       Impact factor: 7.396

6.  Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma.

Authors:  Mathieu Boissan; Eléonore Beurel; Dominique Wendum; Colette Rey; Yann Lécluse; Chantal Housset; Marie-Lise Lacombe; Christèle Desbois-Mouthon
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

7.  Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas.

Authors:  H Miyoshi; C Rust; P J Roberts; L J Burgart; G J Gores
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

Review 8.  Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation.

Authors:  Margaret A Shupnik
Journal:  Oncogene       Date:  2004-10-18       Impact factor: 9.867

9.  IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF).

Authors:  Bernhard Saile; Paola DiRocco; Joszef Dudas; Hammudeh El-Armouche; Holger Sebb; Christoph Eisenbach; Katrin Neubauer; Giuliano Ramadori
Journal:  Lab Invest       Date:  2004-08       Impact factor: 5.662

10.  Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury.

Authors:  Karmene Ahamed; Ralph Epaud; Martin Holzenberger; Monique Bonora; Jean-François Flejou; Julien Puard; Annick Clement; Alexandra Henrion-Caude
Journal:  Respir Res       Date:  2005-04-08
View more
  4 in total

1.  Bile Acid Toxicity and Protein Kinases.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin.

Authors:  C Daniel De Magalhaes Filho; Laurent Kappeler; Joëlle Dupont; Julien Solinc; Sonia Villapol; Cécile Denis; Marika Nosten-Bertrand; Jean-Marie Billard; Annick Blaise; François Tronche; Bruno Giros; Christiane Charriaut-Marlangue; Saba Aïd; Yves Le Bouc; Martin Holzenberger
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

3.  Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury.

Authors:  Andrea Villar-Lorenzo; Patricia Rada; Esther Rey; Patricia Marañón; Ana I Arroba; Beatriz Santamaría; Jorge Sáiz; Francisco J Rupérez; Coral Barbas; Carmelo García-Monzón; Ángela M Valverde; Águeda González-Rodríguez
Journal:  Dis Model Mech       Date:  2019-07-16       Impact factor: 5.758

4.  Targeted therapies in the treatment of advanced hepatocellular carcinoma.

Authors:  Zhengyu Wei; Cataldo Doria; Yuan Liu
Journal:  Clin Med Insights Oncol       Date:  2013-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.